Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Roche Diagnostics India first private firm to get COVID-19 test approval

      Roche Diagnostics India first private firm to get COVID-19 test approval

      Medical Dialogues Bureau20 March 2020 10:00 AM IST
      New Delhi: Roche Diagnostics India has received the license from the country's drug regulator DCGI for its ''Cobas SARS CoV-2'' diagnostic test kit,...
      NPPA, regularly monitoring situations of  prices and availability  of essentials  medicines, says Minister

      NPPA, regularly monitoring situations of prices and availability of essentials medicines, says Minister

      Medical Dialogues Bureau19 March 2020 3:15 PM IST
      Delhi: The Minister for Chemicals & Fertilizers Shri. D.V. Sadananda Gowda informed the Lok Sabha in written reply today that NPPA is...
      CDSCO lays down the Timeline for testing of various classes of New drugs

      CDSCO lays down the Timeline for testing of various classes of New drugs

      Medical Dialogues Bureau19 March 2020 2:33 PM IST
      New Delhi: To streamline the process of testing for approval of all categories of drugs, the Central Drugs Standard Control Organization(CDSCO),...
      Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata

      Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata

      Medical Dialogues Bureau19 March 2020 12:56 PM IST
      Baricitinib is currently approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA).
      Cipla joins hands with CSIR-IICT to develop coronavirus drug

      Cipla joins hands with CSIR-IICT to develop coronavirus drug

      Medical Dialogues Bureau19 March 2020 12:10 PM IST
      Hyderabad: Hyderabad-based CSIR-Indian Institute of Chemical Technology (IICT) has tied up with pharmaceutical giant Cipla to work on the...
      Pfizer, Biontech join hands to co-develop mRNA-based coronavirus vaccine

      Pfizer, Biontech join hands to co-develop mRNA-based coronavirus vaccine

      Medical Dialogues Bureau19 March 2020 11:00 AM IST
      New York & Mainz: Pfizer Inc.and BioNTech SE has announced that the companies have agreed to a letter of intent regarding the co-development and...
      Emami share buyback size likely to be Rs 900-1000 crore

      Emami share buyback size likely to be Rs 900-1000 crore

      Medical Dialogues Bureau19 March 2020 9:00 AM IST
      Kolkata: The size of proposed buyback of shares by Emami Ltd is likely to be in the range of Rs 900-1,000 crore, sources said on Monday. The promoters...
      NPPA orders Surgical, Protective Masks makers, importers to provide data

      NPPA orders Surgical, Protective Masks makers, importers to provide data

      Medical Dialogues Bureau18 March 2020 5:26 PM IST
      Delhi: Through a recent Office Memorandum National Pharmaceutical Pricing Authority(NPPA), Ministry of Chemicals & Fertilizers has ordered all the...
      Price fixation of drugs saves Rs 12,447 crores per annum, says NPPA data

      Price fixation of drugs saves Rs 12,447 crores per annum, says NPPA data

      Medical Dialogues Bureau18 March 2020 2:46 PM IST
      National Pharmaceutical Pricing Authority (NPPA), as an ongoing process, fixes the ceiling prices of the formulations as and when formulations are...
      Regeneron, Sanofi begin testing use of Arthritis Drug Kevzara to treat COVID-19

      Regeneron, Sanofi begin testing use of Arthritis Drug Kevzara to treat COVID-19

      Medical Dialogues Bureau18 March 2020 12:24 PM IST
      Kevzara is a fully-human monoclonal antibody that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor.The use of...
      Alembic Pharma gets USFDA EIR for API Facility at Karakhadi

      Alembic Pharma gets USFDA EIR for API Facility at Karakhadi

      Medical Dialogues Bureau18 March 2020 12:00 PM IST
      Gujrat: Alembic Pharmaceuticals Limited has announced that it has received Establishment Inspection Report (EIR) from US Food and Drug Administration...
      Dr Reddys Labs launches Ziprasidone Mesylate for Injection in US Market

      Dr Reddy's Labs launches Ziprasidone Mesylate for Injection in US Market

      Medical Dialogues Bureau18 March 2020 10:00 AM IST
      Hyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of Ziprasidone Mesylate for Injection, 20 mg (base)/mL Single-dose...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok